Final data on response rate for the Phase II trial with IPH 1101 in Follicular Lymphoma reported at the EHA meeting
Innate Pharma announces its participation to major upcoming medical meetings
New data presented at the Annual Meeting of the American Society of Hematology (“ASH”)
